Elderberry (Sambucus)
A traditional cold and flu remedy with mixed, low-certainty evidence for modestly shorter symptoms.
What is Elderberry (Sambucus)?
Elderberry (Sambucus) (Sambucus nigra) is a gut and immune supplement used for may modestly shorten the duration of upper respiratory symptoms (cold/flu) by roughly 1-4 days in some small trials, though the most rigorous trial found no benefit. NutriDex grades the human evidence as Preliminary. Black elderberry (Sambucus nigra) is a long-used folk remedy for colds and influenza, and its dark berries are rich in anthocyanins with antiviral activity in laboratory studies. A 2019 meta-analysis of four small RCTs (180 participants) reported a substantial reduction in upper respiratory symptoms, and a 2016 air-travellers trial found shorter, less severe colds with supplementation. However, a 2021 systematic review of five RCTs (~624 participants) rated the evidence as very low certainty, and the largest, most rigorous trial (2020, 87 influenza patients) found no benefit and a possible signal of prolonged symptoms when used alone. Overall the human evidence is preliminary and mixed: any benefit on symptom duration appears modest at best and is not firmly established. Critically, raw or unripe berries, leaves, stems, and bark contain cyanogenic glycosides that can cause cyanide-type poisoning, so only properly cooked/commercial preparations should be consumed.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Duration of upper respiratory (cold/flu) symptomsSmall trials/2019 meta-analysis suggest ~1-4 days shorter, but the most rigorous flu RCT found no benefit (and possible harm alone). | Mixed | ↔ mixed · small | 4 |
| Cold symptom severityAir-travellers RCT and small trials suggest reduced severity when started early; overall very low certainty. | Preliminary | ↑ benefit · small | 2 |
| Influenza when used aloneFDA-approved ER RCT (n=87) found no benefit and a post hoc ~2-day worse-symptom signal when taken without oseltamivir. | Preliminary | ⚠ risk · small | 1 |